Literature DB >> 15308772

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals.

Carl T Bergstrom1, Monique Lo, Marc Lipsitch.   

Abstract

Hospital-acquired infections caused by antibiotic-resistant bacteria pose a grave and growing threat to public health. Antimicrobial cycling, in which two or more antibiotic classes are alternated on a time scale of months to years, seems to be a leading candidate in the search for treatment strategies that can slow the evolution and spread of antibiotic resistance in hospitals. We develop a mathematical model of antimicrobial cycling in a hospital setting and use this model to explore the efficacy of cycling programs. We find that cycling is unlikely to reduce either the evolution or the spread of antibiotic resistance. Alternative drug-use strategies such as mixing, in which each treated patient receives one of several drug classes used simultaneously in the hospital, are predicted to be more effective. A simple ecological explanation underlies these results. Heterogeneous antibiotic use slows the spread of resistance. However, at the scale relevant to bacterial populations, mixing imposes greater heterogeneity than does cycling. As a consequence, cycling is unlikely to be effective and may even hinder resistance control. These results may explain the limited success reported thus far from clinical trials of antimicrobial cycling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308772      PMCID: PMC516561          DOI: 10.1073/pnas.0402298101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Antibiotic cycling: is it ready for prime time?

Authors:  J F John
Journal:  Infect Control Hosp Epidemiol       Date:  2000-01       Impact factor: 3.254

Review 2.  [Cyclic rotation of antibiotics. Is all that glitters gold?].

Authors:  Alberto Sandiumenge; Jordi Rello
Journal:  Enferm Infecc Microbiol Clin       Date:  2003-02       Impact factor: 1.731

Review 3.  Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help?

Authors:  J E McGowan
Journal:  Infect Control       Date:  1986-12

Review 4.  Increasing prevalence of antimicrobial resistance in intensive care units.

Authors:  S K Fridkin
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

Review 5.  Impact of antibiotic resistance on clinical outcomes and the cost of care.

Authors:  M S Niederman
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

6.  Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.

Authors:  M H Kollef; J Vlasnik; L Sharpless; C Pasque; D Murphy; V Fraser
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

7.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.

Authors:  A C White; R L Atmar; J Wilson; T R Cate; C E Stager; S B Greenberg
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

8.  Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.

Authors:  Didier Gruson; Gilles Hilbert; Frederic Vargas; Ruddy Valentino; Nam Bui; Sabine Pereyre; Christianne Bebear; Cecile-Marie Bebear; Georges Gbikpi-Benissan
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

9.  The economic impact of Staphylococcus aureus infection in New York City hospitals.

Authors:  R J Rubin; C A Harrington; A Poon; K Dietrich; J A Greene; A Moiduddin
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

Review 10.  Hospital-acquired infections: diseases with increasingly limited therapies.

Authors:  M N Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more
  116 in total

1.  Cycling antibiotics may not be good for your health.

Authors:  Bruce R Levin; Marc J M Bonten
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

2.  Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations.

Authors:  Gabriel G Perron; Alexander E G Lee; Yun Wang; Wei E Huang; Timothy G Barraclough
Journal:  Proc Biol Sci       Date:  2011-11-02       Impact factor: 5.349

3.  Multidrug therapy and evolution of antibiotic resistance: when order matters.

Authors:  Gabriel G Perron; Sergey Kryazhimskiy; Daniel P Rice; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

Review 4.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 5.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

Review 6.  Mathematical modeling of the transmission and control of foodborne pathogens and antimicrobial resistance at preharvest.

Authors:  Cristina Lanzas; Zhao Lu; Yrjo T Gröhn
Journal:  Foodborne Pathog Dis       Date:  2010-11-02       Impact factor: 3.171

Review 7.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  The community-wide dilemma of hospital-acquired drug resistance.

Authors:  Leslie A Real
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

9.  Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.

Authors:  D Andes; A Forrest; A Lepak; J Nett; K Marchillo; L Lincoln
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

10.  Upgrading antibiotic use within a class: tradeoff between resistance and treatment success.

Authors:  Y Claire Wang; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.